Newsroom

ATLANTA--(BUSINESS WIRE)--NCR Atleos Corporation (NYSE: NATL) (“Atleos” or the “Company”) today announced the results of its previously announced consent solicitation (the “Consent Solicitation”) with respect to certain amendments (the “Amendments”) to the indenture (the “Indenture”) governing its 9.500% Senior Secured Notes due 2029 (the “Notes”). As of March 11, 2026 and according to the information received by D.F. King & Co. Inc., consents to the Amendments had been provided and not val...

上海--(BUSINESS WIRE)--(美国商业资讯)-- 专注于提升日常健康的消费健康公司Haleon将投资6500万英镑，在上海新建一座现代化口腔健康生产基地。该基地将支持其口腔护理产品组合——包括全球品牌Sensodyne和parodontax——进军中国快速增长的二线和三线城市。当地收入提升、日常健康意识增强，以及对可信品牌产品的偏好转变，正在重塑消费者行为。 在这一趋势下，越来越多的消费者将预防性口腔护理纳入日常自我护理流程，对高端、有科学依据的解决方案需求快速增长。此次投资将强化Haleon的本地生产布局，助力企业在这一极具活力的市场把握长期增长机遇。 中国是全球最大的牙龈健康市场，规模约达8.6亿英镑。中国超过70%的成年人存在不同程度的牙龈问题，且对牙龈出血、红肿、敏感等症状的认知不断提升，为经过临床验证的牙龈健康产品带来巨大市场机遇。 Haleon增长最快的口腔健康品牌parodontax是中国首款经临床验证、能够分解顽固牙菌斑、从根源改善牙龈出血的牙膏，而牙菌斑是引发牙龈疾病的主要原因。然而，其核心活性成分碳酸氢钠带来的独特感官体验，与许多口味更甜或更偏花香的本...

SALT LAKE CITY--(BUSINESS WIRE)--PROG Holdings, Inc. (NYSE:PRG), the fintech holding company for Progressive Leasing, Four Technologies, MoneyApp, and Purchasing Power, hosted its Investor Day in New York City on March 10, 2026. Members of the PROG leadership team outlined the Company’s strategy to evolve from a leasing-centric business to a multi-product consumer access platform and shared consolidated three-year compound annual growth rates expected for select financial metrics. “Investor Day...

NEW YORK--(BUSINESS WIRE)--iHeartMedia and FOX Entertainment today announced that the 2026 iHeartRadio Music Awards will feature performances by Alex Warren, Lainey Wilson, Ludacris, RAYE, and performing for the first time together TLC, Salt-N-Pepa and En Vogue. Ludacris will host the annual event and also receive the 2026 iHeartRadio Landmark Award. Additionally, Miley Cyrus will be honored with the 2026 iHeartRadio Innovator Award and Alex Warren will receive the 2026 iHeartRadio Breakthrough...

上海--(BUSINESS WIRE)--(美國商業資訊)-- 專注于提升日常健康的消費健康公司Haleon將投資6500萬英鎊，在上海新建一座現代化口腔健康生產基地。該基地將支援其口腔護理產品組合——包括全球品牌Sensodyne和parodontax——進軍中國快速成長的中級和次級城市。當地收入提升、日常健康意識強化，以及對可信品牌產品的偏好改變，正在重塑消費者行為。 在這一趨勢下，越來越多的消費者將預防性口腔護理納入日常自我護理流程，對頂級、有科學依據的解決方案需求快速成長。此次投資將強化Haleon的本地生產布局，協助企業在這一極具活力的市場把握長期成長機會。 中國是全球最大的牙齦健康市場，規模約達8.6億英鎊。中國超過70%的成年人存在不同程度的牙齦問題，且對牙齦出血、紅腫、敏感等症狀的認知不斷提升，為經過臨床驗證的牙齦健康產品帶來龐大市場商機。 Haleon成長最快的口腔健康品牌parodontax是中國首款經臨床驗證、能夠分解頑固牙菌斑、從根源改善牙齦出血的牙膏，而牙菌斑是引發牙齦疾病的主要原因。然而，其核心活性成分碳酸氫鈉帶來的獨特感官體驗，與許多口味更甜或更偏花香的本...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against CoreWeave, Inc. (NasdaqGS: CRWV), if they purchased or otherwise acquired the Company’s securities between March 28, 2025 and December 15, 2025, inclusive (the “Class Period”). This action is pending in the U...

SAN FRANCISCO--(BUSINESS WIRE)--Salesforce (NYSE: CRM), the world’s #1 AI CRM, today announced that it has priced an underwritten offering (the “offering”) in aggregate principal amount of $25 billion in senior notes (the “notes”). The offering is expected to close on March 13, 2026, subject to the satisfaction of customary closing conditions. Salesforce intends to use all of the net proceeds from the offering, after deducting underwriting discounts and estimated offering expenses payable by Sa...

LYON, Francia--(BUSINESS WIRE)--Eurofins Biomnis, proveedor europeo líder en servicios especializados de diagnóstico clínico y parte de la red internacional de laboratorios Eurofins, anuncia el desarrollo y la validación satisfactorios de un nuevo método de cromatografía líquida acoplada a espectrometría de masas en tándem (LC-MS/MS) para la detección y cuantificación de la toxina cereulida en muestras de heces humanas. Esta innovación destaca la innovación diagnóstica de Eurofins Biomnis y su...

LYON, Frankreich--(BUSINESS WIRE)--Eurofins Biomnis, ein führender europäischer Anbieter von spezialisierten klinischen Diagnostikdienstleistungen, der zum globalen Netzwerk der Eurofins-Labore gehört, kündigt die erfolgreiche Entwicklung und Validierung einer neuen Flüssigchromatographie-Tandem-Massenspektrometrie-Methode (Liquid Chromatography Tandem Mass Spectrometry, LC-MS/MS) zum Nachweis und zur Quantifizierung von Cereulid-Toxin in menschlichen Stuhlproben an. Diese Innovation unterstrei...

LIONE, Francia--(BUSINESS WIRE)--Eurofins Biomnis, azienda europea leader nella fornitura di servizi specializzati di diagnostica clinica e parte della rete globale di laboratori Eurofins, annuncia il successo dello sviluppo e della convalida di un nuovo metodo di spettrometria di massa tandem e cromatografia liquida (LC‑MS/MS) per il rilevamento e la quantificazione della tossina cereulide in campioni fecali umani. Questa innovazione sottolinea la novità diagnostica di Eurofins Biomnis, nonché...